| Q60678750 | Chapter 46 Pain following spinal cord injury |
| Q46913406 | Clonidine effects on pain evoked SII activity in humans |
| Q79970197 | Comparison of the anti-allodynic and antinociceptive effects of systemic; intrathecal and intracerebroventricular morphine in a rat model of central neuropathic pain |
| Q34659433 | Descending control of pain |
| Q43631736 | Effects of intrathecal morphine, baclofen, clonidine and R-PIA on the acute allodynia-like behaviours after spinal cord ischaemia in rats |
| Q44658659 | Electrophysiologic characterization of the antinociceptive actions of S18616, a novel and potent alpha2-adrenoceptor agonist, after acute and persistent pain states |
| Q46083475 | Emerging drugs for neuropathic pain |
| Q36651111 | Instrumental learning within the spinal cord: underlying mechanisms and implications for recovery after injury |
| Q38132137 | Mechanisms of electroacupuncture-induced analgesia on neuropathic pain in animal model |
| Q34279399 | Pain following spinal cord injury |
| Q34185102 | Pharmacologic treatment of neuropathic pain |
| Q37165500 | Pharmacological management of neuropathic pain following spinal cord injury |
| Q39880717 | Spinal cord compression injury in adult rats initiates changes in dorsal horn remodeling that may correlate with development of neuropathic pain |
| Q43894965 | Spinal transection increases the potency of clonidine on the tail-flick and hindlimb flexion reflexes |
| Q39064699 | The Polyanalgesic Consensus Conference (PACC): Recommendations for Intrathecal Drug Delivery: Guidance for Improving Safety and Mitigating Risks |
| Q48284194 | The induction of pain: an integrative review |
| Q37065365 | Validity of acute and chronic tactile sensory testing after spinal cord injury in rats |